Sectors & Industries HealthcareHealth Information Services
Best Health Information Service Stocks to Buy Now (2026)
Top health information service stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best health information service stocks to buy now. Learn More.

Industry: Health Information Servic...

Price Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Health Information Services is Zen Rated B and is the 40th ranked industry out of 145 stock market industries

Ticker	Company	Zen Rating	Value	Growth	Momentum	Sentiment	Safety	Financials	AI	1w Zen Rating	1m Zen Rating	3m Zen Rating	1y Zen Rating
OMCL	OMNICELL INC	A	B	B	C	A	B	C	C	A	A	A	B
BTSG	BRIGHTSPRING HEALTH SERVICES INC	A	C	A	B	B	B	B	C	B	B	B	A
PGNY	PROGYNY INC	B	C	B	C	C	B	A	C	A	A	B	B
GDRX	GOODRX HOLDINGS INC	B	A	C	C	C	C	B	C	B	B	C	B
DH	DEFINITIVE HEALTHCARE CORP	B	B	C	C	B	C	C	C	B	B	B	B

Upgrade to Premium to View More

Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +28.50% annually. Learn More

Already have access to Premium?

Health Information Service Stocks FAQ

What are the best health information service stocks to buy right now in Nov 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best health information service stocks to buy right now are:

1. Omnicell (NASDAQ:OMCL)

Omnicell (NASDAQ:OMCL) is the #1 top health information service stock out of 49 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Omnicell (NASDAQ:OMCL) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: C.

Omnicell (NASDAQ:OMCL) has a Due Diligence Score of 57, which is 25 points higher than the health information service industry average of 32.

OMCL passed 18 out of 33 due diligence checks and has strong fundamentals. Omnicell has seen its stock return 9.14% over the past year, overperforming other health information service stocks by 81 percentage points.

Omnicell has an average 1 year price target of $53.75, an upside of 46.66% from Omnicell's current stock price of $36.65.

Omnicell stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Omnicell, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Brightspring Health Services (NASDAQ:BTSG)

Brightspring Health Services (NASDAQ:BTSG) is the #2 top health information service stock out of 49 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Brightspring Health Services (NASDAQ:BTSG) is: Value: C, Growth: A, Momentum: B, Sentiment: B, Safety: B, Financials: B, and AI: C.

Brightspring Health Services (NASDAQ:BTSG) has a Due Diligence Score of 49, which is 17 points higher than the health information service industry average of 32.

BTSG passed 17 out of 33 due diligence checks and has strong fundamentals. Brightspring Health Services has seen its stock return 104% over the past year, overperforming other health information service stocks by 176 percentage points.

Brightspring Health Services has an average 1 year price target of $76.00, an upside of 13.62% from Brightspring Health Services's current stock price of $66.89.

Brightspring Health Services stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Brightspring Health Services, 76.92% have issued a Strong Buy rating, 23.08% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Progyny (NASDAQ:PGNY)

Progyny (NASDAQ:PGNY) is the #3 top health information service stock out of 49 with a Zen Rating of B. Stocks with a rating of B have had an average return of +17.17% per year. Learn more.

The Component Grade breakdown for Progyny (NASDAQ:PGNY) is: Value: C, Growth: B, Momentum: C, Sentiment: C, Safety: B, Financials: A, and AI: C.

Progyny (NASDAQ:PGNY) has a Due Diligence Score of 55, which is 23 points higher than the health information service industry average of 32.

PGNY passed 18 out of 33 due diligence checks and has strong fundamentals. Progyny has seen its stock return 56.51% over the past year, overperforming other health information service stocks by 128 percentage points.

Progyny has an average 1 year price target of $33.50, an upside of 14.77% from Progyny's current stock price of $29.19.

Progyny stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 10 analysts covering Progyny, 70% have issued a Strong Buy rating, 10% have issued a Buy, 20% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the health information service stocks with highest dividends?

Out of 4 health information service stocks that have issued dividends in the past year, the 3 health information service stocks with the highest dividend yields are:

1. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 10.4%, which is 7 percentage points higher than the health information service industry average of 3.42%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 138.6% indicates that its high dividend yield might not be sustainable for the long-term.

2. Nrc Health (NASDAQ:NRC)

Nrc Health (NASDAQ:NRC) has an annual dividend yield of 2.69%, which is -1 percentage points lower than the health information service industry average of 3.42%. Nrc Health's dividend payout is not stable, having dropped more than 10% four times in the last 10 years. Nrc Health's dividend has not shown consistent growth over the last 10 years.

Nrc Health's dividend payout ratio of 250% indicates that its dividend yield might not be sustainable for the long-term.

3. Healthstream (NASDAQ:HSTM)

Healthstream (NASDAQ:HSTM) has an annual dividend yield of 0.4%, which is -3 percentage points lower than the health information service industry average of 3.42%. Healthstream's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Healthstream's dividend has not shown consistent growth over the last 10 years.

Healthstream's dividend payout ratio of 18.3% indicates that its dividend yield is sustainable for the long-term.

Why are health information service stocks down?

Health information service stocks were down -1.99% in the last day, and up 0.9% over the last week.

We couldn't find a catalyst for why health information service stocks are down.

What are the most undervalued health information service stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued health information service stocks right now are:

1. Nutex Health (NASDAQ:NUTX)

Nutex Health (NASDAQ:NUTX) is the most undervalued health information service stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Nutex Health has a valuation score of 43, which is 25 points higher than the health information service industry average of 18. It passed 3 out of 7 valuation due diligence checks.

Nutex Health's stock has gained 60.76% in the past year. It has overperformed other stocks in the health information service industry by 133 percentage points.

2. Carecloud (NASDAQ:CCLD)

Carecloud (NASDAQ:CCLD) is the second most undervalued health information service stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Carecloud has a valuation score of 71, which is 53 points higher than the health information service industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Carecloud's stock has dropped -41.53% in the past year. It has overperformed other stocks in the health information service industry by 30 percentage points.

3. Goodrx Holdings (NASDAQ:GDRX)

Goodrx Holdings (NASDAQ:GDRX) is the third most undervalued health information service stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Goodrx Holdings has a valuation score of 29, which is 11 points higher than the health information service industry average of 18. It passed 2 out of 7 valuation due diligence checks.

Goodrx Holdings's stock has gained 1.45% in the past year. It has overperformed other stocks in the health information service industry by 73 percentage points.

Are health information service stocks a good buy now?

51.35% of health information service stocks rated by analysts are a strong buy right now. On average, analysts expect health information service stocks to rise by 13.88% over the next year.

4.76% of health information service stocks have a Zen Rating of A (Strong Buy), 30.95% of health information service stocks are rated B (Buy), 54.76% are rated C (Hold), 7.14% are rated D (Sell), and 2.38% are rated F (Strong Sell).

What is the average p/e ratio of the health information services industry?

The average P/E ratio of the health information services industry is 11.78x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.